Conjugates of phthalimide with small-molecule inhibitors (degronimids) that recruit the ubiquitin-proteasome system to selectively degrade target proteins Table 1 two topcapitalized startups from Europe and Asia. Overall, US biopharma startups dwarf firms from other areas in terms of capitalization and number (Fig. 1) ; Ireland and the UK are punching above their weight; European companies continue to be comparatively undercapitalized. Those few biotech firms started in China were funded exceptionally well ( Table 2) . A u s t r a l i a B e l g i u m I t a l y S w i t z e r l a n d I s r a e l T h e N e t h e r l a n d s G e r m a n y I r e l a n d C a n a d a C h i n a F r a n c e U K U S 76   9  8  4  4  3  3  3  3  2  2  2  1  1 
